Sign Up Today and Learn More About Alpha Biopharma Stock
Invest in or calculate the value of your shares in Alpha Biopharma or other pre-IPO companies through EquityZen's platform.
Alpha Biopharma Stock (ALPB)
Alpha Biophama is a clinical stage biopharmaceutical company.
About Alpha Biopharma Stock
Founded
2017
Industries
Software, Artificial Intelligence, Data and Analytics
Alpha Biopharma is supported by the domestic and foreign famous funds, and committed to the clinical development of global innovator drug. The company collaborates with the large-scale international drug companies to ensure the preliminary research and development of the product is solid and reliable. By using the powerful scientific consultant and management team and developing the optimization strategy for innovative drug development, the company lay emphasis on the multi-dimensional layout: research and development/market/intellectual property protection. The specifictest operation and business development are collaborated with the international/domestic topCRO/CMO/hospital/institute, and ensure the program is rational and orderly implementation by using the company’s impeccable project management system.
Alpha Biopharma Press Mentions
Stay in the know about the latest news on Alpha Biopharma
AKITA, by Finnadvance’s Post
linkedin • Aug 04, 2024
China’s Alpha Biopharma seeks new drug status for EGFR-TKI product
bioworld • Feb 01, 2023
Alpha Biopharma Management
Leadership team at Alpha Biopharma
Founder
Liu Zhonghai
Chief Operational Officer
James Liu
Join now and verify your accreditation status to gain access to:
- Alpha Biopharma current valuation
- Alpha Biopharma stock price
- Available deals in Alpha Biopharma and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Alpha Biopharma stock?
Accredited investors can buy pre-IPO stock in companies like Alpha Biopharma through EquityZen funds. These investments are made available by existing Alpha Biopharma shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Alpha Biopharma stock?
Shareholders can sell their Alpha Biopharma stock through EquityZen's private company marketplace. EquityZen's network includes over 320K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
